CIBC World Markets Inc. Sells 5,769 Shares of Keysight Technologies Inc (KEYS)

Share on StockTwits

CIBC World Markets Inc. cut its stake in shares of Keysight Technologies Inc (NYSE:KEYS) by 46.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,736 shares of the scientific and technical instruments company’s stock after selling 5,769 shares during the quarter. CIBC World Markets Inc.’s holdings in Keysight Technologies were worth $446,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. ELM Advisors LLC bought a new position in shares of Keysight Technologies during the third quarter valued at approximately $101,000. Dupont Capital Management Corp bought a new position in shares of Keysight Technologies during the second quarter valued at approximately $102,000. Qube Research & Technologies Ltd bought a new position in shares of Keysight Technologies during the second quarter valued at approximately $120,000. Smithfield Trust Co. grew its holdings in shares of Keysight Technologies by 2,786.7% during the third quarter. Smithfield Trust Co. now owns 2,165 shares of the scientific and technical instruments company’s stock valued at $143,000 after purchasing an additional 2,090 shares during the last quarter. Finally, First Hawaiian Bank bought a new position in shares of Keysight Technologies during the third quarter valued at approximately $149,000. 86.07% of the stock is owned by institutional investors.

Several equities analysts have recently commented on KEYS shares. Jefferies Financial Group upped their target price on Keysight Technologies to $74.00 and gave the company a “buy” rating in a report on Wednesday, August 22nd. Deutsche Bank upped their target price on Keysight Technologies from $66.00 to $80.00 and gave the company a “buy” rating in a report on Wednesday, August 22nd. Citigroup upped their target price on Keysight Technologies from $71.00 to $73.00 and gave the company a “buy” rating in a report on Wednesday, August 22nd. Stifel Nicolaus started coverage on Keysight Technologies in a report on Monday, October 22nd. They set a “buy” rating and a $73.00 target price for the company. Finally, Goldman Sachs Group raised Keysight Technologies from a “neutral” rating to a “buy” rating in a report on Thursday, October 18th. Ten analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. Keysight Technologies presently has an average rating of “Buy” and a consensus target price of $71.22.

Shares of NYSE KEYS opened at $58.68 on Friday. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.63 and a quick ratio of 1.20. The company has a market cap of $11.43 billion, a PE ratio of 19.56 and a beta of 1.20. Keysight Technologies Inc has a 12-month low of $41.33 and a 12-month high of $70.40.

Keysight Technologies (NYSE:KEYS) last issued its quarterly earnings data on Tuesday, November 20th. The scientific and technical instruments company reported $0.96 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.84 by $0.12. The business had revenue of $1.05 billion during the quarter, compared to the consensus estimate of $1.02 billion. Keysight Technologies had a return on equity of 22.80% and a net margin of 4.25%. The business’s revenue was up 19.7% on a year-over-year basis. During the same period in the previous year, the firm posted $0.71 earnings per share. On average, analysts predict that Keysight Technologies Inc will post 3.5 earnings per share for the current year.

In other news, CFO Neil Dougherty sold 3,999 shares of the business’s stock in a transaction that occurred on Thursday, September 27th. The stock was sold at an average price of $65.57, for a total transaction of $262,214.43. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Ingrid A. Estrada sold 15,462 shares of the business’s stock in a transaction that occurred on Monday, December 3rd. The stock was sold at an average price of $62.26, for a total value of $962,664.12. Following the transaction, the senior vice president now owns 92,121 shares of the company’s stock, valued at $5,735,453.46. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 224,508 shares of company stock valued at $13,389,170. Insiders own 0.97% of the company’s stock.

TRADEMARK VIOLATION WARNING: “CIBC World Markets Inc. Sells 5,769 Shares of Keysight Technologies Inc (KEYS)” was posted by BBNS and is the property of of BBNS. If you are accessing this piece of content on another domain, it was illegally stolen and reposted in violation of international copyright legislation. The correct version of this piece of content can be viewed at https://baseballnewssource.com/2018/12/08/cibc-world-markets-inc-sells-5769-shares-of-keysight-technologies-inc-keys/3063950.html.

Keysight Technologies Profile

Keysight Technologies, Inc provides electronic design and test solutions to communications and electronics industries internationally. Its Communications Solutions Group segment provides radio frequency and microwave test instruments and related software, and electronic design automation (EDA) software tools; oscilloscopes, logic and serial protocol analyzers, logic-signal sources, arbitrary waveform generators, and bit error rate testers; optical modulation analyzers, component analyzers, power meters, and laser source products, as well as optical amplifier, filter, and other passive component solutions; and related software solutions.

Recommended Story: What are the risks of holding treasury bonds?

Institutional Ownership by Quarter for Keysight Technologies (NYSE:KEYS)

Receive News & Ratings for Keysight Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keysight Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.